SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10069	Companies
205864	Keywords
136124	Articles
109155	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/09/2025 at 07:00, 9 months 14 days ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 9 months 17 days ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
BRIEF

published on 06/06/2025 at 20:27, 9 months 17 days ago

Sanofi annonce un rachat d'actions propres début juin 2025

Rachat D'actions Marché XPAR 2025 Sanofi Transaction Sur Actions
PRESS RELEASE

published on 06/06/2025 at 20:22, 9 months 17 days ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 9 months 17 days ago

Sanofi : Déclaration des transactions sur actions propres
Sanofi déclare les transactions sur actions propres du 02 Juin 2025 au 06 Juin 2025 conformément à la réglementation. Présentation agrégée par jour et par marché

Actions Propres Transactions Réglementation Sanofi Présentation Agrégée
BRIEF

published on 06/02/2025 at 07:05, 9 months 21 days ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
BRIEF

published on 06/02/2025 at 07:05, 9 months 21 days ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
PRESS RELEASE

published on 06/02/2025 at 07:00, 9 months 21 days ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 9 months 24 days ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/30/2025 at 07:05, 9 months 24 days ago

L'itepekimab atteint son critère d'évaluation principal dans l'étude de phase 3 sur la BPCO

Sanofi BPCO Regeneron Itepekimab AERIFY-1

Accesswire

Published on 03/24/2026 at 00:55, 4 hours 41 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 6 hours 56 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 7 hours 6 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 7 hours 36 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 8 hours 18 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 05:10, 25 minutes ago

Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers
Published on 03/24/2026 at 02:00, 3 hours 36 minutes ago

Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 4 hours 40 minutes ago

mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
Published on 03/24/2026 at 00:09, 5 hours 26 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 7 hours 30 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings

Les Echos

Published on 03/23/2026 at 19:08, 10 hours 27 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 10 hours 27 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 10 hours 58 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 11 hours 50 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 11 hours 50 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE